C-Phycocyanin Attenuates Cisplatin-Induced Nephrotoxicity in Mice

REFERENCES

• Jones BR, Bhalla RB, Mladek J, . Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther. 1980;27(4):557–562.
   Google Scholar
• Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis. 1986;8(5):368–379.
   PubMed Web of Science ®Google Scholar
• Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: A review. Am J Med Sci. 2007;334(2):115–124.
   PubMed Web of Science ®Google Scholar
• Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Toxicology. 1989;59(2):151–162.
   Google Scholar
• Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol. 2004;287(3):F543–F549.
   PubMed Web of Science ®Google Scholar
• Jo SK, Cho WY, Sung SA, Kim HK, Won NH. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005;67(2):458–466.
   PubMed Web of Science ®Google Scholar
• Francescato HD, Costa RS, Da Silva CG, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sci. 2009;84(17–18):590–597.
   Google Scholar
• Francescato HD, Costa RS, Junior FB, Coimbra TM. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant. 2007;22(8):2138–2148.
   PubMed Web of Science ®Google Scholar
• Luo J, Tsuji T, Yasuda H, . The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23(7):2198–2205.
   Google Scholar
• Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med. 2004;8(4):445–454.
   PubMed Web of Science ®Google Scholar
• Tsuruya K, Ninomiya T, Tokumoto M, . Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int. 2003;63(1):72–82.
   Google Scholar
• Lissi EA, Pizarro M, Aspee A, Romay C. Kinetics of phycocyanine bilin groups destruction by peroxyl radicals. Free Radic Biol Med. 2000;28(7):1051–1055.
   Google Scholar
• Romay C, Armesto J, Remirez D, . Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res. 1998;47(1):36–41.
   Web of Science ®Google Scholar
• Khan M, Varadharaj S, Ganesan LP, . C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol. 2006;290(5):H2136–H2145.
   PubMed Web of Science ®Google Scholar
• Farooq SM, Asokan D, Sakthivel R, Kalaiselvi P, Varalakshmi P. Salubrious effect of C-phycocyanin against oxalate-mediated renal cell injury. Clin Chim Acta. 2004;348(1–2):199–205.
   Google Scholar
• Lee KW, Jeong JY, Lim BJ, . Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology. 2009;257(3):137–143.
   Google Scholar
• Choi DE, Jeong JY, Lim BJ, . Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol. 2009;297(2):F362–F370.
   PubMed Web of Science ®Google Scholar
• Li XL, Xu G, Chen T, . Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int J Biochem Cell Biol. 2009;41(7):1526–1535.
   PubMed Web of Science ®Google Scholar
• Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol. 2004;18(1):37–52.
   Google Scholar
• Kang DG, Lee AS, Mun YJ, . Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull. 2004;27(3):366–370.
   PubMed Web of Science ®Google Scholar
• Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005;365(9457):417–430.
   PubMed Web of Science ®Google Scholar
• Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology. 2007;230(1):64–75.
   PubMed Web of Science ®Google Scholar
• Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. 2007;230(2–3):256–264.
   Google Scholar
• Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat. 2005;8(1–2):5–14.
   Google Scholar
• Faubel S, Ljubanovic D, Reznikov L, . Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int. 2004;66(6):2202–2213.
   PubMed Web of Science ®Google Scholar
• Wei Q, Dong G, Franklin J, Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 2007;72(1):53–62.
   Google Scholar
• Jiang M, Wang CY, Huang S, Yang T, Dong Z. Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am J Physiol Renal Physiol. 2009;296(5):F983–F993.
   Google Scholar
• Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001;60(5): 1726–1736.
   PubMedGoogle Scholar
• Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem. 2000;275(50):39435–39443.
   PubMed Web of Science ®Google Scholar
• Sanchez-Perez I, Murguia JR, Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene. 1998;16(4):533–540.
   Google Scholar
• Persons DL, Yazlovitskaya EM, Cui W, Pelling JC. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res. 1999;5(5):1007–1014.
   Google Scholar
• Ramesh G, Kimball SR, Jefferson LS, Reeves WB. Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells. Am J Physiol Renal Physiol. 2007;292(2):F812–F819.
   Google Scholar
• Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 2005;289(1):F166–F174.
   PubMed Web of Science ®Google Scholar